Article info
Inflammatory bowel disease
Original article
Interleukin-1β (IL-1β) promotes susceptibility of Toll-like receptor 5 (TLR5) deficient mice to colitis
- Correspondence to Andrew T Gewirtz, Department of Pathology, Emory University School of Medicine, WBRB, Room 105H, 615 Michael Street, Atlanta, GA 30322, USA; agewirt{at}emory.edu
Citation
Interleukin-1β (IL-1β) promotes susceptibility of Toll-like receptor 5 (TLR5) deficient mice to colitis
Publication history
- Revised May 2, 2011
- Accepted May 3, 2011
- First published June 5, 2011.
Online issue publication
April 18, 2016
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.